|
AU8889601A
|
|
Substituted hydrazine derivatives
|
|
AU8357301A
|
|
The use of histamine H<sub>3</sub> receptor inverse agonists for the control of appetite and treatment of obesity
|
|
CA2419073A1
|
|
Novel alicyclic imidazoles as h3 agents
|
|
US2003069295A1
|
|
Use of histamine H3 receptor inverse agonists for the control of appetite and treatment of obesity
|
|
WO0181317A1
|
|
Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
|
|
US6448282B1
|
|
1H-4(5)-substituted imidazole derivatives
|
|
US6416975B1
|
|
Human glycine transporter type 2
|
|
CA2302317A1
|
|
A process for inhibiting complement activation via the alternative pathway
|
|
AU8505698A
|
|
Derivatives of 1-((3,3-dimethyl-3-silabutoxy)methyl)-2-(phenylsulfonyl)imid azole
|
|
US6008240A
|
|
2-(1H-4(5)-imidazoyl) cyclopropyl derivatives
|
|
EP0841923A1
|
|
1h-4(5)-substituted imidazole derivatives
|
|
US6072057A
|
|
1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor agents
|
|
CN1192144A
|
|
1H-4(5)-substituted imidazole derivatives
|
|
US5652258A
|
|
2-(4-imidazoyl) cyclopropyl derivatives
|
|
AU7642494A
|
|
Inhibition of beta amyloid binding to glycosaminoglycans for treatment of alzheimer's disease
|
|
US5705178A
|
|
Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
|
|
US5605938A
|
|
Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
|
